S&P 500
(1.26%) 5 127.79 points
Dow Jones
(1.18%) 38 676 points
Nasdaq
(1.99%) 16 156 points
Oil
(-1.22%) $77.99
Gas
(5.65%) $2.15
Gold
(0.02%) $2 310.10
Silver
(-0.16%) $26.79
Platinum
(0.37%) $966.20
USD/EUR
(-0.35%) $0.929
USD/NOK
(-1.07%) $10.87
USD/GBP
(-0.11%) $0.797
USD/RUB
(0.36%) $91.45

Actualizaciones en tiempo real para OncoZenge AB (publ) [ONCOZ.ST]

Bolsa: STO Sector: Healthcare Industria: Biotechnology
Última actualización3 may 2024 @ 11:02

-1.41% SEK 3.84

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:02):

OncoZenge AB (publ), a pharmaceutical company, develops healthcare products for cancer supportive care. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis...

Stats
Volumen de hoy 12 097.00
Volumen promedio 29 030.00
Capitalización de mercado 44.98M
EPS SEK-0.357 ( 2023-10-31 )
Próxima fecha de ganancias ( SEK0 ) 2024-05-30
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -2.82
ATR14 SEK0.0880 (2.29%)

OncoZenge AB (publ) Correlación

10 Correlaciones Más Positivas
10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

OncoZenge AB (publ) Finanzas

Annual 2023
Ingresos: SEK3 000.00
Beneficio Bruto: SEK3 000.00 (100.00 %)
EPS: SEK-1.360
FY 2023
Ingresos: SEK3 000.00
Beneficio Bruto: SEK3 000.00 (100.00 %)
EPS: SEK-1.360
FY 2022
Ingresos: SEK0
Beneficio Bruto: SEK0 (0.00 %)
EPS: SEK-3.98

Financial Reports:

No articles found.

OncoZenge AB (publ)

OncoZenge AB (publ), a pharmaceutical company, develops healthcare products for cancer supportive care. It offers BupiZenge, which has completed Phase 2 clinical trial for the treatment of oral mucositis. The company was founded in 2020 and is headquartered in Bromma, Sweden. OncoZenge AB (publ) is a subsidiary of Moberg Pharma AB (publ).

Acerca de Señales en Vivo

Las señales en vivo presentadas en esta página ayudan a determinar cuándo COMPRAR o VENDER NA. Las señales tienen un retraso de más de 1 minuto; como todas las señales del mercado, existe la posibilidad de error o errores.

Las señales de trading en vivo no son definitivas y getagraph.com no asume ninguna responsabilidad por cualquier acción tomada sobre estas señales, como se describe en los Términos de Uso. Las señales se basan en una amplia gama de indicadores de análisis técnico